Growth Metrics

Lucid Diagnostics (LUCD) Cost of Revenue (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Cost of Revenue readings, the most recent being $1.9 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 53.55% to $1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.2 million, a 34.02% decrease, with the full-year FY2025 number at $6.7 million, down 59.48% from a year prior.
  • Cost of Revenue hit $1.9 million in Q4 2025 for Lucid Diagnostics, up from $1.7 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $14.1 million in Q4 2022 to a low of -$6.0 million in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $2.8 million (2023), compared with a mean of $2.6 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 2629.17% in 2022 and later tumbled 142.56% in 2023.
  • Lucid Diagnostics' Cost of Revenue stood at -$1.3 million in 2021, then skyrocketed by 1214.11% to $14.1 million in 2022, then plummeted by 142.56% to -$6.0 million in 2023, then surged by 166.54% to $4.0 million in 2024, then plummeted by 53.55% to $1.9 million in 2025.
  • The last three reported values for Cost of Revenue were $1.9 million (Q4 2025), $1.7 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.